Article

The future promise of advanced therapies in ophthalmology

Six years after the first approved gene therapy in ophthalmology, the field is seeing a flurry of activity in innovative cell and gene therapy (CGT) studies addressing high unmet needs. Here’s what could be in store for the future.

Louis Cicchini
Director, Scientific Affairs, Cell & Gene Therapy at Cencora

Fill out the form below to read more

Pardot Form

Related resources

Webinar

Preparing for 2026 health policy changes and their impact on pricing, affordability, and access

Learn more

Webinar

The evolving anti-obesity medication market: Payer trends, policy shifts, and access strategies

Learn more

Article

Mitigating regulatory risk with holistic CMC strategies

Learn more

Connect with our cell and gene experts

Schedule some time with our cell and gene experts today. We look forward to hearing from you.